Author Affiliations1Kirov State Medical Academy 610027, Kirov, Karl Marks str., 112
2Kirov Research Institute of Hematology and Blood Transfusion 610027, Kirov, Krasnoarmeiskaya str., 72
3Kirov Research Institute of Hematology and Blood Transfusion 610027, Kirov, Krasnoarmeiskaya str., 72
4Kirov Research Institute of Hematology and Blood Transfusion 610027, Kirov, Krasnoarmeiskaya str., 72
5Kirov Research Institute of Hematology and Blood Transfusion 610027, Kirov, Krasnoarmeiskaya str., 72
1. Balharek T., Barthova M., Szepe P. et al. Commentary on development of the prognostic factors concept in chronic lymphocytic leukemia: the route from prognostic factors to therapy response predictors // Klin. Onkol. 2009. 22. (6). 254–263.
2. Bulian P., Tarnani M., Rossi D. et al. Multicenter validation of a prognostic index for overall survival in chronic lymphocytic leukaemia // Hematol. Oncol. 2011. 29. (2). 91–99.
3. Cramer P., Hallek M. Prognostic factors in chronic lymphocytic leukemia – what do we need to know? // Nat. Rev. Clin. Oncol. 2011. 8. 38–47.
4. Furman R.R. Prognostic markers and stratification of chronic lymphocytic leukemia // ASH Education Book. 2010. 2010. (1). 77–81.
5. Kardum-Skelin I., Planinc-Peraica A., Ostojic Kolonic S. et al. Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases // Acta Med. Croatica. 2008. 62. (4). 351–364.
6. Kay N.E., O’Brien S.M., Pettitt A.R., Stilgenbauer S. The role of prognostic factors in assessing ‘high-risk’ subgroups of patients with chronic lymphocytic leukemia // Leukemia. 2007. 21. (9). 1885–1891.
7. Mao J., Mao Z.R., Zhou R. Research progress on prognostic markers of chronic lymphocytic leukemia // Zhejiang Da Xue Xue Bao Yi Xue Ban. 2010. 39. (3). 250–256.
8. Morabito F., Cutrona G., Gentile M. et al. Definition of progression risk based on combinations of cellular and molecular markers in patients with Binet stage A chronic lymphocytic leukaemia // Br. J. Haematol. 2009. 146. (1). 44–53.
9. Moreno C., Montserrat E. New prognostic markers in chronic lymphocytic leukemia // Blood Revs. 2008. 22. (4). 211–219.
10. Oscier D., Wade R., Davis Z. et al. Prognostic factors identified three risk groups in the LRF CLL4 trial, independent of treatment allocation // Haematol. 2010. 95. (10). 1705–1712.
11. Pepper C., Majid A., Lin T. Defining the prognosis of early stage chronic lymphocytic leukaemia patients // Br. J. Haematol. 2012. 156 (4). 499–507.
12. Vroblova V., Smolej L., Vrbacky F. et al. Biological prognostic markers in chronic lymphocytic leukemia // Acta Medica. 2009. 52. (1). 3–8.
About Authors (Correspondence):
Zagoskina T.P. – candidate of medical sciences, assistant professor of the chair of hospital diseases, е-mail: zagoskina@blood.kirov.ru
Zotina E.N. – junior researcher of hematology clinic, е-mail: enzotina@mail.ru
Yovdiy A.V. – candidate of medical sciences, junior researcher of the laboratory of immunohematology
Kryukova M.G. – candidate of medical sciences, researcher of the laboratory of immunology of leukemia
Shardakov V.I. – doctor of medical sciences, professor, head of the laboratory of immunology of leukemia
